Awards of Restricted Stock

On November 13, 2017 George C. Carpenter IV, President and Chief Executive Officer of the Company; Donald D’Ambrosio, Chief Financial Officer and the Chairman Robin L. Smith were each granted 7,500 shares of restricted common stock as satisfaction of certain performance criteria.

Equity Purchase Agreement

On November 13, 2017, the Company entered into an equity purchase agreement (the “Arcadian Agreement”) with Arcadian Telepsychiatry Services LLC (“Arcadian”) and Mr. Robert Plotkin, pursuant to which the Company acquired all of the issued and outstanding membership interests (the “Equity Interests”) of Arcadian from Mr. Plotkin. Consideration for the Equity Interests consisted of the assumption of debt and cancellation of Arcadian’s warrants given to a third party of approximately $960,000 and the forgiveness of the note due from Mr. Plotkin of approximately $297,000, for a total purchase price of $1,277,000.